Why all the talk of “modular content”? Is it implementable? What will it allow?
Pharma companies are expected to bring value to HCPs by creating compelling and orchestrated omnichannel journeys. Of course, there is a fair amount of hurdles along the way:
- Creating marketing assets is consuming ever more time and effort
- Expectations from stakeholders are rising
- MLR approvals are getting tougher or are delayed, etc.
A pharmaceutical company translated innovative thinking into tangible benefits, particularly accelerated time-to-market, reduced costs, faster MLR approval process, and easier managerial workflows in general.
Download our latest case study for free to dive deeper into the modular approach implementation process.
You can access the ebook using the form below.
Latest News
September 14, 2023
The pharma sector now reconsiders its procurement process for improved efficiency, resilience, and cost optimization. Discover the innovative approaches that pharma brands employ to effectively address …
August 3, 2023
The Viseven team visits South Korea to monitor the latest transformations in the pharmaceutical industry after Covid-19 and promote omnichannel marketing.
July 26, 2023
The Viseven team met representatives of other companies at their booth, participated in several panels, and learned more about technology and artificial intelligence.
